Rankings
▼
Calendar
WVE
Wave Life Sciences Ltd.
$3B
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$4M
+37.5% YoY
Gross Profit
-$37M
-889.1% margin
Operating Income
-$50M
-1201.5% margin
Net Income
-$47M
-1141.4% margin
EPS (Diluted)
$-1.38
QoQ Revenue Growth
+73.4%
Cash Flow
Operating Cash Flow
-$26M
Free Cash Flow
-$27M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$239M
Total Liabilities
$210M
Stockholders' Equity
$29M
Cash & Equivalents
$121M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4M
$3M
+37.5%
Gross Profit
-$37M
-$37M
+0.2%
Operating Income
-$50M
-$48M
-4.2%
Net Income
-$47M
-$44M
-7.5%
← FY 2020
All Quarters
Q2 2020 →
WVE Q1 2020 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena